secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0000950170-24-079672
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until Dec 23, 2024
--------------------------------------------------------------------------------

- Received Nasdaq Staff letter on June 25, 2024, for failure to meet minimum $1.00 bid price requirement.
- Has 180 calendar days, until December 23, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If noncompliant by Dec 23, may be eligible for additional 180-day period if meets other listing standards and intends to cure via reverse stock split.
- Failure to regain compliance could result in delisting; company will monitor and evaluate options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024079672/0000950170-24-079672-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024079672/apvo-20240625.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-079672

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer